| Name: | (S) Cangliflozin Furanose impurity |
| Catalogue No. | VE007521 |
| CAS No. | N/A |
| Molecular Formula | C24H25FO5S |
| Molecular Weight | 444.52 g/mol |
| Status | In-Stock |
| IUPAC Name | (2R,3R,4R,5R)-2-((S)-1,2-dihydroxyethyl)-5-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydrofuran-3,4-diol |
| Description | (S) Cangliflozin Furanose impurity (CAS No: N/A) Or (2R,3R,4R,5R)-2-((S)-1,2-dihydroxyethyl)-5-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydrofuran-3,4-diol,(S) Cangliflozin Furanose is an impurity of Cangliflozin, which is a novel medication for treatment of type 2 diabetes. |
| References | Sci-Hub | Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms | 10.1038/s41598-018-23420-4. (2018). Retrieved December 31, 2021, from Sci-hub.ee website: https://sci-hub.ee/10.1038/s41598-018-23420-4 |
